Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
TerminatedNCT03793712
Official study titleInterventional, Randomized, Double-blind, Parallel-group, Placebo-controlled, Fixed-flexible-dose Study of Lu AF11167 for the Treatment of Persistent Prominent Negative Symptoms in Patients With Schizophrenia
This study ended early.
Multiple locations, including BurgasSchizophreniaMedication studyAges 18–55
- Countries
- Bulgaria, Czechia, Estonia, + 5 others
- Sponsor
- H. Lundbeck A/S
Active Not RecruitingNCT03995121
About this title
SV2 PET Imaging With [11C]APP311
Read the official source — NCT03995121Official study titleSynaptic Density in Psychiatric Disorders Using SV2A Receptor PET Imaging With [11C]APP311
This study is no longer accepting new participants.
In New HavenSchizophrenia, AddictionObservational studyAges 18–85
- Countries
- United States
- Sponsor
- Yale University
CompletedNCT01698216
About this title
Switching From Consta® to Sustenna® in Patients With Schizophrenia
Read the official source — NCT01698216Official study titleSwitching From Risperidone Long Acting Injection (Consta®) to Paliperidone Palmitate (Sustenna®) in Patients With Schizophrenia and Its Influence on Subjective Well-Being: A Prospective Observational Study
This study has finished and is no longer accepting participants.
In SeoulSchizophreniaObservational studyAges 18–65
- Countries
- South Korea
- Sponsor
- Seoul National University Hospital
CompletedNCT03067311
Official study titleTargeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy (I-CAT)
This study has finished and is no longer accepting participants.
Multiple locations, including CarrboroSchizophreniaBehavioural studyAges 15–35
- Countries
- United States
- Sponsor
- University of North Carolina, Chapel Hill
TerminatedNCT02227563
Official study titletDCS & Auditory Hallucinations in Schizophrenia (AVH-SZ)
This study ended early.
In JerusalemSchizophreniaDevice studyAges 18–60
- Countries
- Israel
- Sponsor
- Herzog Hospital
CompletedNCT02011529
About this title
TEAMcare for Diabetes in Mental Health Centers
Read the official source — NCT02011529Official study titleA Team Approach to Improve the Quality of Diabetes Care for Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In SeattleSchizophreniaInterventional studyAges 18–70
- Countries
- United States
- Sponsor
- University of Washington
UnknownNCT06562504
Official study titleTranscranial Electrical Stimulation Combined With Interim Testing Promotes Temporal Memory in Patients With Schizophrenia
Current recruitment status is unconfirmed.
In LanzhouSchizophreniaDevice studyAges 18–50
- Countries
- China
- Sponsor
- Xiaofeng Ma
CompletedNCT02928965
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 16–35
- Countries
- Sponsor
- University of Manchester
TerminatedNCT00206947
Official study titlePHARMACOLOGICAL TREATMENT OF COGNITIVE DEFICITS IN SCHIZOPHRENIC PATIENTS: The Effects of Central Cholinergic Augmentation on Cognitive Deficits and Psychopathology
This study ended early.
Multiple locations, including CopenhagenSchizophreniaMedication studyAges 18–55
- Countries
- Denmark
- Sponsor
- Birte Glenthoj
TerminatedNCT01137799
Official study titleA Double-Blind, Placebo-Controlled, Randomized, Four-Way Cross-Over Study To Investigate Effect Of Single Oral Doses Of JNJ-39393406 On Event-Related Potentials In Subjects With Stable Schizophrenia
This study ended early.
Multiple locations, including BerlinSchizophreniaMedication studyAges 18–55
- Countries
- Germany
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
CompletedNCT01165294
About this title
The Effect of Ketamine on Attentiveness
Read the official source — NCT01165294Official study titleInvestigate the Effect of S-Ketamine, as Pharmacological Model of Schizophrenia, on the Attentiveness and Working Memory Simultaneously Measured With Functional Magnetic Resonance Imaging(fMRI)/Electroencephalogram(EEG)
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–35
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT06859112
Official study titleThe Effect Of Logotherapy-Based Psychoeducatıon Applıed To Famıly Members Of Indıvıduals Dıagnosıs Of Schızophrenıa On Meanıng In Lıfe, Hope And Depressıon And Theır Psychoeducatıon Experıences
This study has finished and is no longer accepting participants.
In ÜmraniyeSchizophreniaInterventional studyAges 18–65
- Countries
- Türkiye
- Sponsor
- aslı zeynep sipahi